Trial Site Detail

 

Drug:
Gemcitabine, docetaxel
Trial:
Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Imatinib Mesylate Refractory Advanced/Metastatic Malignant GIST
Conditions: Sarcoma; Malignant GIST
Trial Status:
Completed

 

China Medical University Hospital

     
Taichung ,
Taiwan

 

Principal Investigator:
 Chang-Fang Chiu
Contact:
 Yung-Hsin Chin 886-2-87923311 ext 17643 yhchin@nhri.org.tw Chung-Huang Chan, PHD 886-2-879233111 Ext. 17643 hubertchan@nhri.org.tw
Activation Status of this Site:
 Closed
Notes about this Site:
China Medical University Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.